Cutaneous Lymphoma Meeting will update on latest developments in the field Folliculotropic Mycosis Fungoides Work Group will review recent expert work...

Read article

Conquer Cancer Foundation/Anna Braglia Endowed Young Investigator Award (YIA) in...

June 1st, 2019

Read article

May

Helsinn Group Announces Upcoming Presentation of Phase 3b data of NEPA (fosnetup...

May 31st, 2019

The NEPA IV formulation was evaluated for safety in the AC setting

Read article

Helsinn and Mundipharma China Pharmaceutical together announce the launch of ALO...

May 9th, 2019

Read article

Helsinn nominated as a Swiss Biotech Success Story 2019/2020 by the Swiss Biotec...

May 7th, 2019

Read article

April

Helsinn Supports Local Art Exhibition, ‘Lugano: Reflections of Light’ by Helidon...

April 17th, 2019

Read article

March

Winners of the second annual Lyfebulb-Helsinn Innovation Summit & Awards in Onco...

March 19th, 2019

Mihir Shah of UE LifeSciences Inc. has been selected as the winner of the 2019 Lyfebulb-Helsinn Innovation Award in Oncology Pierluigi Paracchi of Gen...

Read article

Helsinn initiates two new global Phase III studies with anamorelin

March 7th, 2019

Helsinn committed to anamorelin which is being evaluated for weight loss and anorexia in patients with advanced non small cell lung cancer (NSCLC) and...

Read article

February

Ten finalists have been chosen for the second annual Lyfebulb-Helsinn Innovation...

February 27th, 2019

The Award recognizes Patient Entrepreneurs’ innovations for cancer and cancer supportive care using therapeutics, diagnostics, medical devices or heal...

Read article

Helsinn Investment Fund Invests €1 Million in Gain Therapeutics

February 19th, 2019

Read article

Helsinn and MEI Pharma Announce Publication of Phase II Data for Pracinostat in ...

February 14th, 2019

Read article

January

Helsinn Provides Educational Grant for ESMO’s Preceptorship for Supportive and P...

January 31st, 2019

Read article